ATP5IF1 and hepatocellular carcinoma: (44) found that ATPase inhibitory factor 1 (IF1) promoted EMT and angiogenesis in HCC after inadequate RFA, that this ability was markedly inhibited after IF1 knockdown, and that the sensitivity of HCC cells to sorafenib was attenuated after RFA via the nuclear factor kappa-B signaling pathway.